제품 정보로 건너뛰기
1 1

Cloud-clone

SKU(재고 관리 코드):PAC688Ra01

Polyclonal Antibody to Osteoglycin (OGN)

Polyclonal Antibody to Osteoglycin (OGN)

UOM
Concentration
Organism species

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

Product No.

PAC688Ra01

Organism Species

Rattus norvegicus (Rat).

Source

Polyclonal antibody preparation

Host

Rabbit

Potency

n/a

Ig Type

IgG

Purification

Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Label

None

Immunogen

RPC688Ra01-Recombinant Osteoglycin (OGN)

Buffer Formulation

PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

Traits

Liquid

Concentration

500µg/mL

Organism Species More

Homo sapiens (Human), Mus musculus (Mouse)

Applications

WB; IHC; ICC; IP.

If the antibody is used in flow cytometry, please check FCM antibodies.

UOM

20µl 100µl 200µl 1ml 10ml

SPECIFITY

The antibody is a rabbit polyclonal antibody raised against OGN. It has been selected for its ability to recognize OGN in immunohistochemical staining and western blotting.

USAGE

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Magazine

Citations

Bone.

Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus. pubmed:27836731

Tohoku journal of experimental medicine

Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease. pubmed:28824047

Molecular Metabolism

Osteoglycin, a novel coordinator of bone and glucose homeostasis Pubmed:29799418

Journal of Experimental & Clinical Cancer Research

Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway Pubmed:29499765

Journal of Human Hypertension

Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients Pubmed:29867136

Cell Reports

Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue Pubmed: 30332637

J Clin Endocrinol Metab

Osteoglycin across the adult lifespan 34850904


Catalog No.

Related products for research use of Rattus norvegicus (Rat) Organism species

Applications (RESEARCH USE ONLY!)

RPC688Ra01

Recombinant Osteoglycin (OGN)

Positive Control; Immunogen; SDS-PAGE; WB.

PAC688Ra01

Polyclonal Antibody to Osteoglycin (OGN)

WB; IHC; ICC; IP.

LAC688Ra71

Biotin-Linked Polyclonal Antibody to Osteoglycin (OGN)

WB; IHC; ICC.

 

전체 세부 정보 보기